Literature DB >> 25800874

Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6.

Seiichiro Mori1, Takamasa Takeuchi2, Yoshiyuki Ishii2, Iwao Kukimoto2.   

Abstract

Recent cancer genomics studies have identified mutation patterns characteristic of APOBEC3B (A3B) in multiple cancers, including cervical cancer, which is caused by human papillomavirus (HPV) infection. A3B expression is upregulated by HPV E6/E7 oncoproteins, implying a crucial role for A3B upregulation in HPV-induced carcinogenesis. Here, we explored the molecular mechanisms underlying the activation of the A3B promoter by E6. Luciferase reporter assays with a series of deleted fragments of the human A3B promoter in normal immortalized human keratinocytes (NIKS) identified two functional regions in the promoter: the distal region (from -200 to -51), which is required for basal promoter activity, and the proximal region (from +1 to +45), which exerts an inhibitory effect on gene expression. Each promoter region was found to contain an E6-responsive element(s). Disruption of an AT-rich motif located between +10 and +16 abrogated the proximal-region-mediated activation of the A3B promoter by E6. DNA pull-down assays revealed that a cellular zinc-finger protein, ZNF384, binds to the AT-rich motif in the A3B promoter, and chromatin immunoprecipitation assays confirmed that ZNF384 binds to the A3B promoter in cells. ZNF384 knockdown reduced the A3B mRNA levels in NIKS expressing E6, but not in the parental NIKS, indicating that ZNF384 contributes to A3B upregulation by E6, but not to basal A3B expression. The exogenous expression of ZNF384 led to the activation of the A3B promoter in NIKS. Collectively, these results indicate that E6 activates the A3B promoter through the distal and proximal regions, and that ZNF384 is required for the proximal-region-mediated activation of A3B.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOBEC3B; E6; Human papillomavirus; Promoter; ZNF384

Mesh:

Substances:

Year:  2015        PMID: 25800874     DOI: 10.1016/j.bbrc.2015.03.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.

Authors:  Kayla L Conner; Asra N Shaik; Elmira Ekinci; Seongho Kim; Julie J Ruterbusch; Michele L Cote; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2020-01-16

2.  Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.

Authors:  Seiichiro Mori; Takamasa Takeuchi; Yoshiyuki Ishii; Takashi Yugawa; Tohru Kiyono; Hiroshi Nishina; Iwao Kukimoto
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

3.  Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome.

Authors:  Yusuke Hirose; Mamiko Onuki; Yuri Tenjimbayashi; Seiichiro Mori; Yoshiyuki Ishii; Takamasa Takeuchi; Nobutaka Tasaka; Toyomi Satoh; Tohru Morisada; Takashi Iwata; Shingo Miyamoto; Koji Matsumoto; Akihiko Sekizawa; Iwao Kukimoto
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

4.  Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.

Authors:  Hal P Bogerd; Anand V R Kornepati; Joy B Marshall; Edward M Kennedy; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

5.  Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers.

Authors:  Prokopios P Argyris; Peter E Wilkinson; Matthew C Jarvis; Kelly R Magliocca; Mihir R Patel; Rachel I Vogel; Rajaram Gopalakrishnan; Ioannis G Koutlas; Reuben S Harris
Journal:  Mod Pathol       Date:  2020-07-06       Impact factor: 7.842

6.  Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.

Authors:  Monica K Akre; Gabriel J Starrett; Jelmar S Quist; Nuri A Temiz; Michael A Carpenter; Andrew N J Tutt; Anita Grigoriadis; Reuben S Harris
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

7.  Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma.

Authors:  Gabriel J Starrett; Christina Marcelus; Paul G Cantalupo; Joshua P Katz; Jingwei Cheng; Keiko Akagi; Manisha Thakuria; Guilherme Rabinowits; Linda C Wang; David E Symer; James M Pipas; Reuben S Harris; James A DeCaprio
Journal:  MBio       Date:  2017-01-03       Impact factor: 7.867

8.  Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study.

Authors:  Shumei Yan; Fan He; Bei Gao; Huini Wu; Mei Li; Liyun Huang; Jianzhong Liang; Qiuliang Wu; Yong Li
Journal:  J Cancer       Date:  2016-03-19       Impact factor: 4.207

9.  High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.

Authors:  Weijing Zhang; Weiling He; Yongjie Shi; Haifeng Gu; Min Li; Zhimin Liu; Yanling Feng; Nianzhen Zheng; Chuanmiao Xie; Yanna Zhang
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

10.  Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.

Authors:  Fu-Fen Yin; Ning Wang; Xiao-Ning Bi; Xiao Yu; Xiao-Hui Xu; You-Lin Wang; Cheng-Quan Zhao; Bing Luo; Yan-Kui Wang
Journal:  Virol J       Date:  2016-04-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.